Difficulty: Medium
Average Score: 64%
Practice
Adalimumab (Humira) is given to a client for the treatment of rheumatoid arthritis. Which of the following side effect is associated with the medication?
Correct answer
D
Rationale
Adalimumab, a tumor necrosis factor (TNF) inhibitor, is associated with weight gain as a potential side effect. This may occur due to fluid retention or changes in metabolism. Numbness, constipation, and urinary retention are not commonly linked to adalimumab. Weight gain is a significant consideration for patients, as it can impact their overall health and adherence to treatment. Monitoring for this side effect is important, and dietary or lifestyle interventions may be necessary to manage it effectively.